Patient Access Solutions Market worth 1.74 Billion USD by 2022

The report "Patient Access Solutions Market by Product & Service (Eligibility Verification, Medical Necessity, Prior-authorization, Denial Management), Delivery Mode (Web & Cloud, On-premise), End User (Providers, Outsourcing Companies) - Global Forecast to 2022", The patient access solutions market is expected to reach USD 1.74 Billion by 2022 from an estimated USD 1.21 Billion in 2017, at a CAGR of 7.6%. Regulatory compliance encouraging the use of patient access solutions, increasing patient volume and the subsequent growth in the demand for health insurance, growing importance of denial management, declining reimbursement rates, and need to curtail escalating healthcare costs are the major factors driving the growth of the patient access solutions market.

Browse 62 market data Tables and 34 Figures spread through 145 Pages and in-depth TOC on "Patient Access Solutions Market by Product & Service (Eligibility Verification, Medical Necessity, Prior-authorization, Denial Management), Delivery Mode (Web & Cloud, On-premise), End User (Providers, Outsourcing Companies) - Global Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/patient-access-solution-market-280473.html
Early buyers will receive 10% customization on reports.

“By product & service, the services segment accounted for the largest share of the patient access solutions market in 2016.”

On the basis of product & service, the services segment accounted for the largest share of the global patient access solutions market. The introduction of complex software and the need for system integration are expected to boost the services market in the near future.

“By delivery mode, the web & cloud-based solutions segment accounted for the largest share of the patient access solutions market in 2016.”

On the basis of delivery mode, the web & cloud-based solutions segment accounted for the largest share of the global patient access solutions market. This segment is also exected to grow at the highest CAGR during the forecast period. Factors such as flexibility of working from remote areas, rising affordability, and features such as auto-upgradation are attributing to the larger share and high growth of the web & cloud-based solutions segment.

“By end users, the healthcare providers segment held the largest market share of patient access solutions market in 2016.”

Based on end user, the healthcare providers segment accounted for the largest share of the patient access solutions market. Increasing healthcare IT adoption, increasing affordability in developing countries, and increasing volume of claims denials are the major factors supporting the adoption of patient access solutions in healthcare providers.

https://www.marketsandmarkets.com/pdfdownload.asp?id=280473

“North America dominated the market in 2016.”

North America accounted for the largest share of the patient access solutions market in 2016, followed by Europe and Asia Pacific. North America’s large share in the global market is attributed to factors such as ever-changing healthcare regulations, transition toward high co-pay by patients, increasing government support for improving healthcare IT infrastructure, increasing volume of claims denials, high number of private and government payers, and the presence of a large number of healthcare IT companies.

Prominent players in the patient access solutions market are McKesson (US), Epic Systems (US), Cerner (US), Cognizant (US), Experian (Ireland), Optum (US), Conifer Health (US), The Advisory Board (US), 3M (US), Craneware (UK), The SSI Group (US), ZirMed (US), Cirius Group (US), and AccuReg Software (US).

Dental Bone Graft Substitutes Market worth 664.3 Million USD by 2021

The report "Dental Bone Graft Substitutes Market by Type (Synthetic Bone Grafts, Xenografts, Allografts, and Demineralized Allografts), by Application (Sinus Lift, Ridge Augmentation, Socket Preservation, Periodontal Defect Regeneration, and Implant Bone Regeneration), by Product (Biooss, Osteograf, Grafton, and Others) - Forecast to 2021", The global dental bone graft substitutes market is expected to reach USD 664.3 Million by 2021, at a CAGR of 9.8% from 2016 to 2021. Factors such as technological advancements in the field of dental bone grafts and increase in the number of bone grafting procedures are expected to drive the growth of the global dental bone grafts substitutes market. Several insurance providers in the U.S. and various countries in the European region have assisted the medical sector to introduce and encourage the usage of latest synthetic bone grafts and demineralized allografts.

Browse 66 market data tables with 69 figures spread through 140 pages and in-depth TOC on "Dental Bone Graft Substitutes Market by Type (Synthetic Bone Grafts, Xenografts, Allografts, and Demineralized Allografts), by Application (Sinus Lift, Ridge Augmentation, Socket Preservation, Periodontal Defect Regeneration, and Implant Bone Regeneration), by Product (Biooss, Osteograf, Grafton, and Others) - Forecast to 2021" 
https://www.marketsandmarkets.com/Market-Reports/dental-bone-graft-substitutes-market-159678690.html
Early buyers will receive 10% customization on reports.

This report mainly considers four types of dental bone graft substitutes – xenograft, synthetic bone grafts, allograft, and demineralized allograft. Using patient’s own bone (autograft) has traditionally been the most preferred method of bone grafting; however, increasing technological advancements have increased the number of synthetic graft options. The benefits of synthetic grafts include availability, sterility, and reduced morbidity. Also, the synthetic bone grafts have a longer shelf life and there is no risk of any disease. Because of these benefits, synthetic bone graft is the fastest-growing type in the dental bone graft substitutes market.

In this report, the dental bone graft substitutes market is segmented into four major geographic segments, namely, North America, Europe, Asia-Pacific, and Rest of the World. Europe is estimated to account for the largest share of the overall dental bone graft substitutes market in 2016. Europe is the region of origin of implant dentistry; therefore, the penetration rate of dental bone graft substitutes is very high in this region. The main factors driving the growth of the European dental market are the increase in aging population, governmental expenditure on oral healthcare across Europe, and the high reimbursement rate although limited to Germany, Sweden, and the Netherlands.

https://www.marketsandmarkets.com/pdfdownload.asp?id=159678690

This research study is aimed at identifying emerging trends and opportunities in the global dental bone graft substitutes market. It provides comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation of the global dental bone graft substitutes market on the basis of type, application, product, and region.

Apart from the market segmentation, this report also makes use of the Porter’s five forces analysis, which provides an in-depth analysis of the market by providing market dynamics, such as drivers, restraints, and opportunities in the global dental bone graft substitutes market.

Prominent players in this market include Institut Straumann AG (Switzerland), Geistlich (Switzerland) DENTSPLY International (U.S.), Zimmer Biomet (U.S.), Medtronic (Ireland), BioHorizons IPH, Inc. (U.S.), ACE Surgical Supply Company, Inc. (U.S.), RTI Surgical, Inc. (U.S.), LifeNet Health (U.S.), and Dentium (Korea).

Neuromodulation Market worth $6.20 Billion by 2020

The report “Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation), by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020” analyzes and studies the major market drivers, restraints, and opportunities.

Browse 84 market data tables and 32 figures spread through 182 pages and in-depth TOC on “Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation), by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020"
https://www.marketsandmarkets.com/Market-Reports/neurostimulation-devices-market-921.html
Early buyers will receive 10% customization on reports.

This report studies the global neuromodulation market from 2015 to 2020. The global neuromodulation market is estimated at $3.65 Billion in 2015, and is projected to reach $6.20 Billion by 2020, at a CAGR of 11.2% during the forecast period. The global neuromodulation market is segmented on the basis of technology, application, and region.

Based on technology, the neuromodulation market is segmented into internal neuromodulation and external neuromodulation. Internal neuromodulation is further segmented into spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), and gastric electrical stimulation (GES). External neuromodulation is categorized into transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), and respiratory electrical stimulation (RES).

Based on application, the neuromodulation market is segmented into technology-wise applications, such as spinal cord stimulation (chronic pain, failed back surgery, ischemia); deep brain stimulation (Parkinsons disease, tremor, depression, others); sacral nerve stimulation (urine incontinence, fecal incontinence); vagus nerve stimulation (epilepsy, others); gastric electrical stimulation (gastro paresis, obesity); transcutaneous electrical nerve stimulation (treatment resistant depression, others); and transcranial magnetic stimulation (depression, migraine headaches).

https://www.marketsandmarkets.com/pdfdownload.asp?id=921

On the basis of region, the market is divided into North America, Europe, Asia-Pacific, and rest of the world (RoW). The rest of the world region comprises Latin America, the Middle East, and Africa. North America is expected to account for the largest share of the neuromodulation market, followed by Europe, Asia-Pacific, and rest of the world (RoW) in 2015.

Factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by players, and expanded target applications and new indications are driving the growth of this market. However, factors such as unfavorable reimbursement scenario and lack of trained professionals are hindering its market growth.

Some of the major players in the global neuromodulation market include Medtronic, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Synapse Biomedical, Inc. (U.S.), Nevro Corporation (U.S.), Neurosigma, Inc. (U.S.), Neuropace, Inc. (U.S.), Neuronetics, Inc. (U.S.), Cyberonics, Inc. (U.S.), and BioControl Medical (Israel).

Atherectomy Devices Market by Type, Application & End User - 2022

The global atherectomy devices market is projected to reach USD 1.45 Billion by 2022 from USD 1.08 Billion in 2017, at a CAGR of 6.1%. The growth witnessed by atherectomy devices is mainly driven by the growing target patient population, continuous product development & commercialization, favorable medical reimbursements, rising demand for minimally invasive atherectomy procedures, and strengthening distribution channels of major product manufacturers.

https://www.marketsandmarkets.com/Market-Reports/atherectomy-devices-market-133112140.html

This report broadly segments the atherectomy devices market into product, application, end user, and region. On the basis of product, the market is categorized into directional, photo-ablative (laser), orbital, rotational atherectomy systems, and support devices. In 2017, the directional atherectomy devices segment is expected to account for the largest share of the market. It is also expected to register the highest CAGR during the forecast period. This can be attributed to the significant availability of credible clinical data to validate their clinical efficacy, rising availability of reimbursements for vascular treatment procedures across developed countries, high preference for minimally invasive procedures among medical professionals, clinical benefits offered, and ongoing technology advancements in the field of directional atherectomy.

Based on application, the atherectomy devices market is categorized into peripheral vascular, cardiovascular, and neurovascular applications. The peripheral vascular applications segment accounted for the largest share of the market and is expected to be the fastest growing segment during the forecast period. The large share of this segment is attributed to the significant availability of clinical evidence to support therapeutic efficacy of atherectomy in PVD treatment and rising availability of medical reimbursements for peripheral atherectomy procedures across developed countries.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=133112140

Based on end user, the atherectomy devices market is segmented into three categories, namely, hospitals and surgical centers, ambulatory care centers, and research laboratories & academic institutes. The hospitals and surgical centers segment accounted for the largest share of the market due to the increasing adoption of atherectomy for cardiac & peripheral vascular disease treatment and growing availability of healthcare reimbursements across major countries.

This report covers the atherectomy devices market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). Of the four geographic regions studied in the report, North America is expected to command the largest share of the market in 2017. Factors such as increasing availability of reimbursements for atherectomy systems, growing adoption of atherectomy systems among medical professionals, large patient population of peripheral & coronary artery diseases, and growing number of clinical trials (that aim to evaluate the therapeutic efficacy of atherectomy systems in specific disease treatment) are driving the growth of the North American atherectomy devices market.

Factors such as stringent regulatory framework, significant adoption of alternative therapies, and dearth of well-trained surgeons to conduct atherectomy procedures are expected to restrain the growth of the atherectomy devices market during the forecast period.

The major players in the atherectomy devices market are Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), Cardiovascular Systems (US), Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US).

Hemostats Market worth 2.76 Billion USD by 2020

The report "Hemostats Market by Product Type (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), and Geography (Americas, Europe, APAC, MEA) - Global Forecast to 2020", The global hemostats market size is anticipated to reach USD 2.76 Billion by 2020, at a CAGR of 6.2% from 2015 to 2020. Factors such as increasing surgical procedures and rising number of insurance providers are driving the hemostats market. According to Center for Disease Control and Prevention (CDC), 51.4 Million surgeries have taken place in the U.S. in 2014. The increase in number of surgeries accelerates the demand for hemostats and thereby is driving the growth of the market. However, the high cost of products hinder the growth of the global hemostats market.

Browse 199 market data Tables and 90 Figures spread through 159 Pages and in-depth TOC on "Hemostats Market by Product Type (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), and Geography (Americas, Europe, APAC, MEA) - Global Forecast to 2020"
https://www.marketsandmarkets.com/Market-Reports/hemostats-market-9571619.html
Early buyers will receive 10% customization on reports.

Based on product type, the global hemostats market is segmented into thrombin-based, oxidized regenerated cellulose based hemostats, combination hemostats, gelatin based hemostats, and collagen based hemostats. The thrombin based hemostats segment dominates the hemostats market and is projected to grow at a significant pace during the forecast period, in terms of value.

Based on geography, the global hemostat market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. Each region is further segmented into countries, covering around 50 countries, globally. The market in the Americas is one of the key geographical segments that generates major revenue in the global hemostats market. The growth in the Americas hemostats market is attributed to the increase in number of surgical procedures. However, the hemostats market in Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period. Increasing healthcare infrastructure along with rise in number of surgeries are propelling the growth of this market.

Major companies operational in the hemostats market are Johnson & Johnson Services, Inc. (U.S.). C. R. Bard, Inc. (U.S.), Baxter (U.S.), B Braun Melsungen AG (Germany), Pfizer Inc. (U.S.), Vascular Solutions, Inc. (U.S.), Gelita Medical GmbH (Germany), Equimedical (Netherlands), Integra Lifesciences Holdings Corporation (U.S.), Z-Medica, LLC (U.S.), and Marine Polymer Technologies, Inc. (U.S.).

https://www.marketsandmarkets.com/pdfdownload.asp?id=9571619

The research study is aimed at identifying emerging trends and opportunities in the global hemostats market along with detailed classifications, in terms of revenue. It provides comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation of the global hemostats market on the basis of product type and geography. Apart from the market segmentation, this report also provides an in-depth analysis of the market by providing a detailed process flow diagram and market dynamics, such as drivers, restraints, and opportunities in the global hemostats market.

About MarketsandMarkets

MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Sunitinib Malate Market worth 76.7 Million USD by 2021

The report "Sunitinib Malate Market Forecast for Pancreatic Cancer, 2016-2017, G7 Countries, (U.S., Germany, France, U.K., Italy, Spain, Japan)", The sunitinib malate market for pancreatic cancer is projected to reach USD 76.7 Million by 2021, at a CAGR of 13.9% from 2016 to 2021.

Browse 14 market data Tables spread through 26 Pages and in-depth TOC on "Sunitinib Malate Market Forecast for Pancreatic Cancer, 2016-2017, G7 Countries, (U.S., Germany, France, U.K., Italy, Spain, Japan)"
https://www.marketsandmarkets.com/Market-Reports/sunitinib-malate-market-194614514.html
Early buyers will receive 10% customization on reports.

A number of factors, such as increasing incidence of pancreatic cancer, availability of a limited number of drug therapeutic options for the treatment of advanced pancreatic neuroendocrine tumors, and poor diagnosis rate in the early stages of pancreatic cancer are driving the demand of sunitinib malate in the treatment of pancreatic cancer. Also, the overall number of patients who are eligible for taking sunitinib malate is expected to grow at a high CAGR during the forecast period.

In this report, the market is segmented into seven country-level segments, namely, the U.S., Germany, France, the U.K., Italy, Spain, and Japan. The U.S. is expected to dominate this market primarily due to the higher number of patients suffering from pancreatic cancer in the country. However, the market in the U.K. is expected to witness the highest growth rate during the forecast period.

https://www.marketsandmarkets.com/pdfdownload.asp?id=194614514

This report contains detailed analysis of the sunitinib malate market for pancreatic cancer in terms of epidemiology, number of drug-treated patients suffering from pancreatic neuroendocrine tumors (pNET), percentage of patients eligible for taking sunitinib malate, penetration of sunitinib malate in pNET patients, number of pancreatic cancer patients, incidence rate of pancreatic cancer, 5-year survival rate of pNET patients, penetration of drug therapy in pancreatic cancer treatment, and trends in the adoption of sunitinib malate. This report also includes pricing analysis of sunitinib malate in all G7 countries and year-on-year market size of sunitinib malate for pancreatic cancer from 2010 to 2021.

Pain Management Devices Market worth 4.64 Billion USD by 2021

The report "Pain Management Devices Market by Device Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Cancer, Neuropathy, Musculoskeletal, Migraine, Facial), by Mode of Purchase (OTC, Prescription-Based) - Global Forecasts to 2021", analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

Browse 117 market data tables with 43 figures spread through 198 pages and in-depth TOC on "Pain Management Devices Market by Device Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Cancer, Neuropathy, Musculoskeletal, Migraine, Facial), by Mode of Purchase (OTC, Prescription-Based) - Global Forecasts to 2021" 
https://www.marketsandmarkets.com/Market-Reports/pain-management-devices-market-91418163.html
Early buyers will receive 10% customization on reports.

This report studies the global pain management devices market over the forecast period of 2016 to 2021. The market is expected to reach ~USD 4.64 Billion by 2021, at CAGR of 8.5% from 2016 to 2021.A number of factors, such as the growing demand for long-term pain management among the geriatric population, large patient population base, adverse effects of pain medications, development of novel pain management device, established reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries, and high proven efficacy of pain management device for the treatment of chronic pain are driving the growth of the global pain management devices market. On the other hand, factors such as low awareness regarding the availability and use of pain management device, shortage of pain specialists, low number of pain clinics in several countries, existence of a gap in prevalence and treatment of chronic pain, and high procedural and purchase cost of pain management device are restricting the growth of the global market.

https://www.marketsandmarkets.com/pdfdownload.asp?id=91418163

This report covers three major pain management device types, namely, neurostimulation devices, ablation devices, and analgesic infusion pumps. The neurostimulation devices segment is expected to witness the highest growth and account for the largest share of the pain management devices market in 2016. This can be attributed to the advantages of neurostimulation over alternative therapies for managing chronic pain. Also, the long-term cost efficiency and technological developments in neurostimulation devices are contributing to the growth of this market segment.

On the basis of application, the global pain management device market is segmented into neuropathic pain, cancer pain, facial pain & migraine, musculoskeletal pain, and others. The neuropathic pain application segment is estimated to witness the highest growth during the forecast period, primarily due to the presence of substantial clinical evidence in the favor of high efficacy of pain management device in neuropathic pain treatment, favorable reimbursement scenario, development of novel neuropathic pain management device, large patient population base, rising geriatric population across the globe, and side effects of drugs used to treat neuropathic pain.

https://www.marketsandmarkets.com/requestsample.asp?id=91418163

Based on the mode of purchase, the market is segmented into over-the-counter (OTC) devices and prescription-based devices. The prescription-based devices segment is expected to account for the largest share of the global pain management devices market in 2016, whereas the OTC devices segment is expected to grow at the highest CAGR during the forecast period. The high growth in this segment is attributed to the availability of a number of OTC devices in the market and FDA approvals for new OTC devices in the coming years.

As of 2016, North America held the largest share of the global pain management devices market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. A number of factors, including growing incidence of chronic diseases, improving healthcare infrastructure in the region, growing middle-class population and disposable income levels, and rising awareness about the safety and efficacy of pain management device are stimulating the growth of the pain management devices market in the Asia-Pacific region.

Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), and St. Jude Medical Inc. (U.S.) are the major players in the global pain management devices market.

Atherectomy Devices Market by Type, Application & End User - 2022

The global atherectomy devices market is projected to reach USD 1.45 Billion by 2022 from USD 1.08 Billion in 2017, at a CAGR of 6.1%. The growth witnessed by atherectomy devices is mainly driven by the growing target patient population, continuous product development & commercialization, favorable medical reimbursements, rising demand for minimally invasive atherectomy procedures, and strengthening distribution channels of major product manufacturers.

https://www.marketsandmarkets.com/Market-Reports/atherectomy-devices-market-133112140.html

This report broadly segments the atherectomy devices market into product, application, end user, and region. On the basis of product, the market is categorized into directional, photo-ablative (laser), orbital, rotational atherectomy systems, and support devices. In 2017, the directional atherectomy devices segment is expected to account for the largest share of the market. It is also expected to register the highest CAGR during the forecast period. This can be attributed to the significant availability of credible clinical data to validate their clinical efficacy, rising availability of reimbursements for vascular treatment procedures across developed countries, high preference for minimally invasive procedures among medical professionals, clinical benefits offered, and ongoing technology advancements in the field of directional atherectomy.

Based on application, the atherectomy devices market is categorized into peripheral vascular, cardiovascular, and neurovascular applications. The peripheral vascular applications segment accounted for the largest share of the market and is expected to be the fastest growing segment during the forecast period. The large share of this segment is attributed to the significant availability of clinical evidence to support therapeutic efficacy of atherectomy in PVD treatment and rising availability of medical reimbursements for peripheral atherectomy procedures across developed countries.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=133112140

Based on end user, the atherectomy devices market is segmented into three categories, namely, hospitals and surgical centers, ambulatory care centers, and research laboratories & academic institutes. The hospitals and surgical centers segment accounted for the largest share of the market due to the increasing adoption of atherectomy for cardiac & peripheral vascular disease treatment and growing availability of healthcare reimbursements across major countries.

This report covers the atherectomy devices market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). Of the four geographic regions studied in the report, North America is expected to command the largest share of the market in 2017. Factors such as increasing availability of reimbursements for atherectomy systems, growing adoption of atherectomy systems among medical professionals, large patient population of peripheral & coronary artery diseases, and growing number of clinical trials (that aim to evaluate the therapeutic efficacy of atherectomy systems in specific disease treatment) are driving the growth of the North American atherectomy devices market.

Factors such as stringent regulatory framework, significant adoption of alternative therapies, and dearth of well-trained surgeons to conduct atherectomy procedures are expected to restrain the growth of the atherectomy devices market during the forecast period.

The major players in the atherectomy devices market are Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), Cardiovascular Systems (US), Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US).

Medical Automation Market is expected to reach USD 55.03 Billion by 2020, at CAGR of 9.5% from 2015 to 2020.

Emerging Asia-Pacific countries, including India and China, offer high growth potential for companies engaged in the development and marketing of automated solutions for the healthcare industry. Growing geriatric population; increasing cases of cardiovascular disease (CVD), diabetes, cancer, and orthopedic diseases; rising clinical research; and growing government expenditure on healthcare and life science research are the key factors propelling the growth of the medical automation market in the emerging countries.

On the basis of application, the medical automation market is divided into four segments, namely, diagnostic and monitoring automation (automated image analysis, automated imaging, and point-of-care testing), therapeutic automation (non-surgical automation and surgical automation), laboratory and pharmacy automation (laboratory automation and pharmacy automation), and medical logistics and training (logistic automation and trainers). The medical logistics and training segment is expected to grow at the highest rate in the next five years, owing to high adoption of these automated systems (pneumatic tubes, AGV, RTLS, and RFID) by big hospitals and diagnostic centers.

The global medical automation market over the forecast period of 2015 to 2020. The market is expected to reach USD 55.03 Billion by 2020, at CAGR of 9.5% from 2015 to 2020.

The therapeutic automation market segment holds the largest share in the global medical automation market. This segment is further categorized on the basis of product into non-surgical automation (defibrillators and automated medication systems) and surgical automation (surgical robots, intraoperative imaging, surgical navigation, intelligent operating rooms, and surgical simulators). In 2015, the non-surgical automation segment held a larger share of 72.9% of the global therapeutic automation market. The increasing incidences of various chronic diseases and technological advancements in defibrillators and medication systems are the key factors contributing to the growth of this market segment.

The global medical automation market is divided into four segments on the basis of end users– hospitals and diagnostic centers, pharmacies, research laboratories and institutes, and home/ambulatory care settings and other end users.

The global medical automation market is estimated to grow at a CAGR of 9.5% from 2015 to 2020. A number of factors such as continuous advancements in various medical automation technologies; increasing government financial support for medical automation; and growing adoption of automation in laboratory, pharmacy, and medical logistics operations are propelling the growth of the global medical automation market. However, high cost of automation and stringency of regulatory procedures leading to delayed product launches are the key factors restraining the growth of this market.

On the basis of geography, medical automation  market is classified into four regions, namely, North America (U.S. and Canada), Europe, Asia-Pacific, and the Rest of the World. In 2015, the global medical automation market is estimated to be dominated by North America. Large number of ongoing clinical trials in the U.S., high adoption rate of technologically advanced medical devices in this region, and developed healthcare reimbursement structure are contributing to the large share of the North American medical automation market. The Asia-Pacific market is expected to grow at the highest CAGR from 2015 to 2020. Factors such as growing government expenditure on healthcare research, rising number of clinical research activities owing to increasing R&D outsourcing to developing Asian countries, increasing old age population and associated diseases, availability of a large patient pool, and developing healthcare infrastructure are propelling the growth of the Asia-Pacific medical automation market.

http://www.marketsandmarkets.com/Market-Reports/medical-automation-technologies-market-848.html

New product launches, product approvals, and product enhancements is the primary growth strategy adopted by major players to enhance their positions in the global medical automation market. Moreover, strategies such as partnerships, agreements, and collaborations; geographic expansions; and acquisitions were also adopted by a significant number of market players to strengthen their product portfolios and expand their geographic presence in the market.

Koninklijke Philips N.V. (Netherlands), Siemens AG (Germany), General Electric Company (U.S.), Intuitive Surgical, Inc. (U.S.), Medtronic plc (U.S.), Tecan Group Ltd. (Switzerland), Stryker Corporation (U.S.), Accuray Incorporated (U.S.), Danaher Corporation (U.S.), and Swisslog Holding AG (Switzerland) are some of the key players operating in the global medical automation market.

Download PDF Brochure:  http://www.marketsandmarkets.com/pdfdownload.asp?id=848

Scope of the Report

This research report categorizes the global medical automation market into the following segments:

Global Diagnostics and Monitoring Automation Market

• Automated Imaging
  • Automated Fluoroscopy
  • Automated Radiography
  • Automated Microscopy
  • Capsule Endoscopy
• Point-of-care Testing (POCT)
• Automated Image Analysis

Global Therapeutic Automation Market

• Non-surgical Automation Market
  • Defibrillators
    • Implantable Cardioverter Defibrillators
    • Automated External (Portable) Defibrillators
    • Wearable Defibrillators
    • Automated Medication Delivery Systems
      • Implantable Drug Pumps
      • Wearable Drug Pumps
• Surgical Automation Market
  • Surgical Robots
    • da Vinci
    • CyberKnife
    • RIO
    • Renaissance
  • Intelligent Operating Rooms
  • Intraoperative Imaging
    • Intraoperative Ultrasound
    • Intraoperative CT
    • Intraoperative MRI
  • Surgical Navigation Systems
  • Surgical Simulators

Global Pharmacy and Laboratory Automation Market

• Laboratory Automation Market
  • Automated Liquid Handling
  • Microplate Readers
  • Software & Informatics
  • Standalone Robots
  • Automated Storage & Retrieval Systems (ASRS)
• Pharmacy Automation Market
  • Automated Medication Dispensing Systems
  • Automated Packaging and Labeling Systems
  • Automated Medication Compounding Systems

Global Medical Logistics & Training Automation Market

• Logistics Automation
  • Hospital Asset/Patient/Staff Tracking Systems Market
    • Radiofrequency Identification
    • Real-time Location Systems (RTLS)
  • Automated Hospital Pickup & Delivery
    • Pneumatic Tube Systems (PTS)
    • Automated Guided Vehicles (AGV)
• Trainers

Global Medical Automation Market, by End User

• Hospitals & Diagnostic Centers
• Research Laboratories & Institutes
• Pharmacies
• Home/Ambulatory Care Settings & Others

Global Medical Automation Market, by Region

• North America
  • U.S.
  • Canada
• Europe
• Asia-Pacific
• Rest of the World

Drug Discovery Informatics Market worth 2.84 Billion USD by 2022

The report "Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Molecular Docking, Library Preparation), Solution (Software, Services), End User (Pharmaceutical & Biotechnology, Contract Research Organization) - Global Forecast to 2022", The global drug discovery informatics market is expected to reach USD 2.84 Billion from USD 1.67 Billion at a CAGR of 11.2%. Rising R&D expenditure and increasing focus on drug discovery are the major factors driving the adoption of discovery informatics solutions.

Browse 63 market data Tables and 25 Figures spread through 115 Pages and in-depth TOC on "Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Molecular Docking, Library Preparation), Solution (Software, Services), End User (Pharmaceutical & Biotechnology, Contract Research Organization) - Global Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/drug-discovery-informatics-market-64537381.html
Early buyers will receive 10% customization on reports.

Based on function, the sequencing and target data analysis segment is accounted for the largest share of the market in 2017

On the basis of function, the drug discovery informatics market is divided into sequencing and target data analysis, docking, molecular modeling, libraries & database preparation, and other functions. In 2017, the sequencing and target data analysis segment is expected to account for the largest share of the drug discovery informatics market. Factors such as the expansive application of informatics solutions in targeted analysis and the large amount of data generated during the drug discovery process are driving the growth of this segment.

Based on solution, the software segment is accounted for the largest share of the market in 2017

The solution segment of the drug discovery informatics market is divided into software and services. In 2017, the software segment is expected to account for the largest share of the global drug discovery informatics market. The dominant share of this market is attributed to the fact that drug discovery informatics software solutions enable the fast and efficient management of data generated throughout the drug discovery process.

https://www.marketsandmarkets.com/pdfdownload.asp?id=64537381

North America is expected to dominate the market in 2017

The North America is expected to account for the largest share of the drug discovery informatics market in 2017. Established pharmaceutical industry with the presence of leading pharmaceutical and biotechnology companies attributes to the largest share of North America. Europe is expected to account for the second-largest share of the drug discovery informatics market.

The key players operating in the drug discovery informatics market are IBM (US), Infosys (India), Schrödinger (US), PerkinElmer (US), and Thermo Fisher Scientific (US).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Clinical Trial Supplies Market worth 1.2 Billion USD by 2020

The report “Clinical Trial Supplies Market by products & Services (Logistics & Distribution, Manufacturing, Packaging and Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorders, Cardiovascular, Oncology) - Global Forecast to 2020” provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the clinical trial supplies market along with the estimates and forecasts of the revenue and market share analysis.

Browse 70 tables and 36 figures spread through 134 pages and in-depth TOC on "Clinical Trial Supplies Market by products & Services (Logistics & Distribution, Manufacturing, Packaging and Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorders, Cardiovascular, Oncology) - Global Forecast to 2020"
https://www.marketsandmarkets.com/Market-Reports/clinical-trial-supplies-market-172240059.html
Early buyers will receive 10% customization on reports.

The global clinical trial supplies market is expected to reach USD 1,274.3 Million by 2020 from USD 904.3 Million in 2015, at a CAGR of 7.1% from 2015 to 2020.

The report segments this market based on products and services, phases, therapeutic areas, and regions. Among the various products and services, the logistics and distribution services segment is expected to account for the largest share of the market and is projected to grow at the highest CAGR from 2015 to 2020. The high growth in this segment can be attributed to the factors such as globalization of clinical trials and increasing outsourcing of services.

On the basis of phases, the clinical trial supplies market is segmented into phase I, phase II, and phase III. The phase III segment is expected to account for the largest share of the global clinical trial supplies market in 2015. Large sample size of patients and high cost of phase III trials are the factors propelling the growth of this market.

https://www.marketsandmarkets.com/pdfdownload.asp?id=172240059

Therapeutic areas, included in the clinical trial supplies market are oncology, cardiovascular diseases, respiratory diseases, CNS and mental disorders, dermatology disorders, blood disorders, infectious diseases, and others. The oncology segment is expected to account for the largest share of the global clinical trial supplies market in 2015. Increase in cancer incidences and government funding for cancer research are factors driving the growth of this market.

Based on regions, the global clinical trial supplies market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as rising prevalence of chronic diseases, growing number of clinical trials, and the increasing number of life sciences research activities in North America.

Key players in the clinical trial supplies market include Alamc Group LTD (U.K.), Biocair (U.K.), Catalent Pharma Solutions, Inc. (U.S.), KLIFO A/S (Denmark), Movianto (Germany), PCI Services (U.S.), Patheon, Inc. (U.S.), PAREXEL International Corporation (U.S.), Sharp Packaging Services (U.S.), and Thermo Fisher Scientific, Inc. (U.S.)

Bioinformatics Market worth 16.18 Billion USD by 202

The report "Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 2021", The bioinformatics market is projected to reach USD 16.18 Billion by 2021 from USD 6.21 Billion in 2016, growing at a CAGR of 21.1% during the forecast period.

Browse 136 market data tables and 47 figures spread through 184 pages and in-depth TOC on “Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 2021”
https://www.marketsandmarkets.com/Market-Reports/bioinformatics-39.html
Early buyers will receive 10% customization on reports.

Growing demand for nucleic acid and protein sequencing, increasing initiatives from government and private organizations, growing application of bioinformatics, and improved collaborative ties between companies and research institutes are the major factors driving the growth of the bioinformatics market. On the other hand, lack of well-defined standards and common data formats for integration of data, shortage of skilled bioinformatics professionals, and lack of adequate user-friendly tools are the major factors restraining the growth of this market.

The bioinformatics market is segmented on the basis of sector, products and services, application, and region. Based on sector, the bioinformatics market is categorized into medical biotechnology, academics, animal biotechnology, agricultural technology, environmental biotechnology, forensic biotechnology, and other sectors (homeland security and defense, law enforcement groups, bioweapon creation, and evolutionary biotechnology). In 2016, the medical biotechnology segment is expected to account for the largest share of the bioinformatics market. This is attributed to the increasing use of bioinformatics in drug discovery and development processes for the faster development of safe and effective drugs at reduced costs.

On the basis of products and services, the bioinformatics market is categorized into knowledge management tools, bioinformatics platforms, and bioinformatics services. The knowledge management tools segment is expected to account for the largest market share in 2016. However, the bioinformatics platforms segment is expected to grow at the highest CAGR during the forecast period; high growth in this segment can be attributed to the advantages of bioinformatics platforms, such as reduction in overall time for processing data, phylogenetic analysis, and identification of sequence similarity.

https://www.marketsandmarkets.com/pdfdownload.asp?id=39

Based on application, the market is segmented into genomics, chemoinformatics & drug design, proteomics, transcriptomics, metabolomics, molecular phylogenetics, and other applications (glycomics, cytomics, physiomics, and interactomics). The genomics segment is expected to account for the largest market share in 2016.. The increasing use of pharmacogenomics is a major factor contributing to the growth of this segment.

North America is expected to account for the largest share of the bioinformatics market in 2016. The increasing demand for bioinformatics across genomics and proteomics research, technological advancements, increasing research funding, and presence of a large number of market players and research institutes are driving the growth of the bioinformatics market in this region.

Major players operating in the bioinformatics market include Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Netherlands), and Agilent Technologies (U.S.).

Optical Imaging Market worth 1.75 Billion USD by 2020

The report "Optical Imaging Market by Technique (OCT, NIRS, HSI, PAT) by Product (Imaging System, Camera, Lens, Software) by Therapeutic Area (Ophthalmology, Oncology, Neurology, Dermatology), by Application (Pathological, Intra-operative) - Global Forecast to 2020", The Global Optical Imaging Market Is Expected to reach USD 1,749.2 Million by 2020. The market was valued at USD 989.0 Million in 2015 and is expected to grow at a CAGR of 12.1% from 2015 to 2020.

Browse 161 market data Tables and 43 Figures spread through 200 Pages and in-depth TOC on "Optical Imaging Market by Technique (OCT, NIRS, HSI, PAT) by Product (Imaging System, Camera, Lens, Software) by Therapeutic Area (Ophthalmology, Oncology, Neurology, Dermatology), by Application (Pathological, Intra-operative) - Global Forecast to 2020"
https://www.marketsandmarkets.com/Market-Reports/optical-imaging-technologies-market-894.html
Early buyers will receive 10% customization on reports.

Owing to the technological advancements and increasing application areas of optical imaging techniques in pharmaceutical and biotechnological industries and medical diagnostics & therapeutics, the optical imaging market recorded a healthy growth rate during last decade. Optical imaging is extensively used for several applications including preclinical research, disease diagnosis, imaging of various cellular and molecular processes in vivo including protein interactions, protein degradation, and protease activity. Thus, increasing research activities in the biopharmaceutical industry and rising applications of optical imaging modalities for therapeutic and diagnostic purposes is expected to have a positive impact on the growth of this market. Moreover, uptake of optical imaging techniques due to growing demand for non-invasive & non-ionizing imaging modalities with ageing population and integration of optical imaging techniques with other imaging modalities is expected to drive the demand for optical imaging products in the coming years. However, high installation cost, complex regulatory requirements, and lack of skilled operators is likely to hinder the growth of the market to a certain extent.

In this report, the global optical imaging market is segmented by techniques, products, applications, end users, geographic regions, and countries. It also discusses the key market drivers, restraints, opportunities, trends, and challenges of this market and its sub-markets.

In 2013, North America accounted for the largest share of the global optical imaging market, followed by Europe and Asia-Pacific. Greater uptake of optical imaging products and the presence of large number of optical imaging products manufacturers in the North American and European region has led to their large market share in the optical imaging market. However, the Asia-Pacific region represents the substantial growth opportunity for the optical imaging market during the forecast period of 2015 to 2020. The growth in this region is primarily driven by increased focus on healthcare growth in geriatric population, rising per capita income, increasing investments in the APAC healthcare industry by key market players, rising demand for cutting-edge technologies, and low labor costs.

https://www.marketsandmarkets.com/pdfdownload.asp?id=894

The prominent players in the optical imaging market include Carl Zeiss Meditec AG (Germany), Bioptigen, Inc. (U.S.), Topcon Medical Systems, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), Canon, Inc. (U.S.), and PerkinElmer, Inc. (U.S.),

About MarketsandMarkets

MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com